ObjectiveIn the context of Healthy China construction, physical-medical integration, as an important way to optimize the allocation of health resources, plays a key role in solving the series of health problems in the process of China’s development and promoting the improvement of the health level of the whole people. This paper aims to carry out a systematic evaluation on physical-medical integration policies in China. MethodsThis paper took 18 physical-medical integration policies issued at the national level from 2016 to 2022 as the research object, used the text mining method to process policy texts, constructed PMC index model, made quantitative evaluation of related policies, and put forward corresponding policy suggestions based on the results. ResultsThe results showed that the physical-medical integration policies in China was relatively perfect in the aspects of policy openness, policy function and policy evaluation, but it still needed to be optimized from the aspects of policy prescription, policy nature, participating subject, policy perspective and policy tools. ConclusionIn the future policy making, it is necessary to improve the policy design, build the mechanism of multi-subject collaborative governance, and adjust the application structure of policy tools, so as to further improve the policy system of physical-medical integration in China and help realize the strategic goal of Healthy China.
ObjectiveTo analyze the policy environment of clinical research in China, providing valuable insights for the formulation and enhancement of policies. MethodsAt the national level in our country, policies related to clinical research were selected as the research subject. The method of text mining was employed to extract high-frequency words from policy texts. By constructing the policy modeling consistency (PMC) index model, evaluations of the relevant policies regarding clinical research in our country were quantified from multiple dimensions including internal consistency, effectiveness, and scope of influence. ResultsThe average PMC index of 22 clinical research policies in our country was 6.87. Among them, 10 policies demonstrated an excellent performance, while 12 policies were considered qualified. This suggested that the overall quality of clinical research policies at the national level was good, yet there was still considerable room for improvement. ConclusionPolicies regarding clinical research have entered a high-speed development stage and exhibit basic completeness in China. However, these policies appear somewhat independent of each other and inadequate rule of law.